APPENDIX

..............page:1801-1804

Hemobilia due to hepatic artery aneurysm as the presenting sign of fibro-muscular dysplasia
Noam Shussman;Yair Edden;Yoav Mintz;Anthony Verstandig;Avraham I Rivkind

..............page:1797-1799

Perforated appendicitis masquerading as acute pancreatitis in a morbidly obese patient
Michael J Forster;Jacob A Akoh

..............page:1795-1796

Herbal compound 861 regulates mRNA expression of collagen synthesis- and degradation-related genes in human hepatic stellate cells
Lin Wang;Bao-En Wang;Jian Wang;Pei-Gen Xiao;Xue-Hai Tan

..............page:1790-1794

Cyclooxygenase 2 polymorphism and colorectal cancer: -765G＞C variant modifies risk associated with smoking and body mass index
Li-Li Xing;Zhen-Ning Wang;Li Jiang;Yong Zhang;Ying-Ying Xu;Juan Li;Yang Luo;Xue Zhang

..............page:1785-1789

Short-term overlap lamivudine treatment with adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B
Soon Woo Nam;Si Hyun Bae;Seung Woo Lee;Yeon Soo Kim;Sang Bum Kang;Jong Young Choi;Se Hyun Cho;Seung Kew Yoon;Joon-Yeol Han;Jin Mo Yang;Young Suk Lee

..............page:1781-1784

Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis
Maarouf A Hoteit;Amaar H Ghazale;Andrew J Bain;Eli S Rosenberg;Kirk A Easley;Frank A Anania;Robin E Rutherford

..............page:1774-1780

Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection
Kazuto Kishimoto;Akira Hokama;Tetsuo Hirata;Yasushi Ihama;Manabu Nakamoto;Nagisa Kinjo;Fukunori Kinjo;Jiro Fujita

..............page:1768-1773

Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis
Tsung-Chieh Shih;Sen-Yung Hsieh;Yi-Yueh Hsieh;Tse-Chin Chen;Chien-Yu Yeh;Chun-Jung Lin;Deng-Yn Lin;Cheng-Tang Chiu

..............page:1759-1767

Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma
Patrick Arbuthnot;Liam Jed Thompson

..............page:1670-1681

Radioembolization for the treatment of unresectable hepatocellular carcinoma: A clinical review
Saad M Ibrahim;Robert J Lewandowski;Kent T Sato;Vanessa L Gates;Laura Kulik;Mary F Mulcahy;Robert K Ryu;Reed A Omary;Riad Salem

..............page:1664-1669

Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era
Douglas C Macdonald;Mark Nelson;Mark Bower;Thomas Powles

..............page:1657-1663

Natural history of hepatitis-related hepatocellular carcinoma
David Yiu-Kuen But;Ching-Lung Lai;Man-Fung Yuen

..............page:1652-1656

Gastric cancer: Animal studies on the risk of hypoacidity and hypergastrinemia
Reidar Fossmark;Gunnar Qvigstad;Helge L Waldum

..............page:1646-1651

Complications of collagenous colitis
Hugh James Freeman

..............page:1643-1645

Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fiction
Yuan-Yuan Zhang;Harry Hua-Xiang Xia

..............page:1641-1642

Genome-wide differences in hepatitis C- vs alcoholism-associated hepatocellular carcinoma
Céline Derambure;Cédric Coulouarn;Frédérique Caillot;Romain Daveau;Martine Hiron;Michel Scotte;Arnaud Francois;Celia Duclos;Odile Goria;Marie Gueudin;Catherine Cavard;Benoit Terris;Maryvonne Daveau;Jean-Philippe Salier

..............page:1749-1758

DNA methylation in hepatocellular carcinoma
Iris Tischoff;Andrea Tannapfel

..............page:1741-1748

Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors pl6 and p27 in hepatocellular carcinoma
Yasunobu Matsuda

..............page:1734-1740

Tumor suppressor and hepatocellular carcinoma
Juliette Martin;Jean-Frangois Dufour

..............page:1720-1733

Current role of ultrasound for the management of hepatocellular carcinoma
Hitoshi Maruyama;Masaharu Yoshikawa;Osamu Yokosuka

..............page:1710-1719

Activins and activin antagonists in hepatocellular carcinoma
Alev Deli;Emanuel Kreidl;Stefan Santifaller;Barbara Trotter;Katja Seir;Walter Berger;Rolf Schulte-Hermann;Chantal Rodgarkia-Dara;Michael Grusch

..............page:1699-1709

Reactivation of the insulin-like growth factor-Ⅱ signaling pathway in human hepatocellular carcinoma
Kai Breuhahn;Peter Schirmacher

..............page:1690-1698

Is human hepatocellular carcinoma a hormone-responsive tumor?
Massimo Di Maio;Bruno Daniele;Sandra Pignata;Ciro Gallo;Ermelinda De Maio;Alessandro Morabito;Maria Carmela Piccirillo;Francesco Perrone

..............page:1682-1689